Re: Medical conflicts of interest: when a declaration isn't enough
Investigators are required to declare conflicts related to their research, the emphasis has traditionally been on transparency . It is evident for a reviewer of scientific literature that the quality of argumentation in some areas of medical and biological research has deteriorated during the past decades. Dubious publication series have been continued without making reference to the published criticism. Another tendency is that substances without proven effects and questionable treatments have been advertized, and corresponding products marketed in the guise of evidence-based medications. Scientific publications are needed for the registration of such drugs and treatments to obtain permissions for the practical use; such publications continue appearing, sometimes being of questionable reliability. In Russia, the marketing of placebos in the guise of evidence-based medications is quite usual; and artificial theoretic concepts are sometimes used for that purpose [2-5]. The criticism has partly remained unnoticed or has been replied to with arguments that have not been commented on.
1. Torjesen I. Medical conflicts of interest: when a declaration isn't enough. BMJ 2018;363:k4660
2. Jargin SV. Glycosaminoglycans and their precursors in osteoarthritis. Open Veterinary Journal 2018 https://www.researchgate.net/publication/327136697_Glycosaminoglycans_an...
3. Comment on "Use of Carnosine for Oxidative Stress Reduction in Different Pathologies". Oxid Med Cell Longev. 2016;2016:5250386
4. Meldonium (Mildronate): Primum nоn nocere. Pharmacol Res. 2016;114:294
5. Invasive procedures with questionable indications: Prevention of a negligent custom. J Surg Open Access 2017;3(5).
Competing interests: No competing interests